oxymatrine has been researched along with oleic acid in 1 studies
| Studies (oxymatrine) | Trials (oxymatrine) | Recent Studies (post-2010) (oxymatrine) | Studies (oleic acid) | Trials (oleic acid) | Recent Studies (post-2010) (oleic acid) |
|---|---|---|---|---|---|
| 412 | 16 | 270 | 8,768 | 248 | 3,051 |
| Protein | Taxonomy | oxymatrine (IC50) | oleic acid (IC50) |
|---|---|---|---|
| Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 6.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gong, ZN; Rao, SY; Xu, GL; Yao, L; Yu, SQ; Zhang, SQ | 1 |
1 other study(ies) available for oxymatrine and oleic acid
| Article | Year |
|---|---|
Attenuation of acute lung injury in mice by oxymatrine is associated with inhibition of phosphorylated p38 mitogen-activated protein kinase.
Topics: Alkaloids; Animals; Dexamethasone; Disease Models, Animal; Drug Administration Schedule; Drug Antagonism; Drug Evaluation, Preclinical; Injections, Intraperitoneal; Injections, Intravenous; Lung; Male; Medicine, Chinese Traditional; Mice; Microscopy, Electron, Scanning; Oleic Acid; Organ Size; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Quinolizines; Respiratory Distress Syndrome; Sophora; Tumor Necrosis Factor-alpha | 2005 |